Gallium-68 prostate-specific membrane antigen positron emission tomography (Ga-68 PSMA PET) accurately detects metastases in biochemically recurrent prostate cancer, particularly at low prostate-specific antigen (PSA) levels, researchers say.
Reuters Health Information
